Next Generation Cell Therapy Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-09-24　·　253 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 7.40 Bn
2033 年預估規模: USD 35.88 Bn
年複合成長率 CAGR: 25.3%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

完整報告名稱與涵蓋範圍

Next Generation Cell Therapy Market, By Cell Type (T Cells, Natural Killer (NK) Cells, Stem Cells, Dendritic Cells, Macrophages, Others), By Therapy Type (CAR-T Cell Therapy, T-Cell Receptor (TCR) Therapy, Tumor-Infiltrating Lymphocyte (TIL) Therapy, CAR-NK Cell Therapy, Stem Cell Therapy, Others), By Source (Autologous, Allogeneic), By Application (Hematological Malignancies, Solid Tumors, Autoimmune Diseases, Genetic Disorders, Neurological Disorders, Others), By End User (Hospitals and Cancer Centers, Pharmaceutical and Biotechnology Companies, Contract Development and Manufacturing Organizations (CDMOs), Academic and Research Institutes, Specialized Cell Therapy Centers, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

報告摘要

The global next generation cell therapy market is estimated to be valued at USD 7.40 Bn in 2026 and is expected to reach USD 35.88 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 25.3% from 2026 to 2033. The global next generation cell therapy market encompasses advanced therapies that utilize living cells to repair, replace or regenerate damaged tissues and treat complicated diseases. These therapies include CAR-T, NK cell, iPSC-derived and gene edited cell therapies with applications across oncology, auto-immune disorders, cardiovascular diseases and rare genetic conditions. Advances in synthetic biology, CRISPR-based genome engineering and cell manufacturing are driving these therapies from research to clinical and commercial applications, while increasing regulatory support, improving manufacturing scalability and increased investment in advanced cellular technologies are further accelerating the development and adoption of next generation cell therapies globally. Market Dynamics The global next generation cell therapy market is driven by the increasing incidence of cancer and chronic diseases, increasing clinical validation of engineered cell therapies and advancements in gene-editing technologies such as CRISPR-Cas9 and base editing. Increasing regulatory support, government funding and development of allogeneic “off-the-shelf” therapies are other factors that are accelerating commercialization and expanding patient accessibility. However, a number of constraints are present in the market, such as high manufacturing costs, complex personalized production, cold-chain requirements and stringent quality controls. Nevertheless, significant opportunities exist within allogeneic cell therapies, AI-enabled manufacturing and patient selection and expansion into solid tumors, autoimmune diseases and neurological disorders supported by increasing collaboration across biotechnology, pharmaceutical and research organizations. Key Features of the Study • This report provides in-depth analysis of the global next generation cell therapy market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global next generation cell therapy market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Novartis AG, Bristol-Myers Squibb Company, Gilead Sciences, Inc., Johnson & Johnson, Legend Biotech Corporation, Autolus Therapeutics plc, Iovance Biotherapeutics, Inc., Adaptimmune Therapeutics plc, Allogene Therapeutics, Inc., and CRISPR Therapeutics AG • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global next generation cell therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global next generation cell therapy market Market Segmentation • Cell Type Insights (Revenue, USD Bn, 2021 - 2033) o T Cells o Natural Killer (NK) Cells o Stem Cells o Dendritic Cells o Macrophages o Others • Therapy Type Insights (Revenue, USD Bn, 2021 - 2033) o CAR-T Cell Therapy o T-Cell Receptor (TCR) Therapy o Tumor-Infiltrating Lymphocyte (TIL) Therapy o CAR-NK Cell Therapy o Stem Cell Therapy o Others • Source Insights (Revenue, USD Bn, 2021 - 2033) o Autologous o Allogeneic • Application Insights (Revenue, USD Bn, 2021 - 2033) o Hematological Malignancies o Solid Tumors o Autoimmune Diseases o Genetic Disorders o Neurological Disorders o Others • End User Insights (Revenue, USD Bn, 2021 - 2033) o Hospitals and Cancer Centers o Pharmaceutical and Biotechnology Companies o Contract Development and Manufacturing Organizations (CDMOs) o Academic and Research Institutes o Specialized Cell Therapy Centers o Others • Regional Insights (Revenue, USD Bn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Novartis AG o Bristol-Myers Squibb Company o Gilead Sciences, Inc. o Johnson & Johnson o Legend Biotech Corporation o Autolus Therapeutics plc o Iovance Biotherapeutics, Inc. o Adaptimmune Therapeutics plc o Allogene Therapeutics, Inc. o CRISPR Therapeutics AG

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Next Generation Cell Therapy Market, By Cell Type  Global Next Generation Cell Therapy Market, By Therapy Type  Global Next Generation Cell Therapy Market, By Source  Global Next Generation Cell Therapy Market, By Application  Global Next Generation Cell Therapy Market, By End User  Global Next Generation Cell Therapy Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Cell Type Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Industry Trends 4. Global Next Generation Cell Therapy Market, By Cell Type, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o T Cells  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Natural Killer (NK) Cells  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Stem Cells  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Dendritic Cells  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Macrophages  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 5. Global Next Generation Cell Therapy Market, By Therapy Type, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o CAR-T Cell Therapy  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o T-Cell Receptor (TCR) Therapy  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Tumor-Infiltrating Lymphocyte (TIL) Therapy  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o CAR-NK Cell Therapy  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Stem Cell Therapy  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 6. Global Next Generation Cell Therapy Market, By Source, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Autologous  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Allogeneic  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 7. Global Next Generation Cell Therapy Market, By Application, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Hematological Malignancies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Solid Tumors  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Autoimmune Diseases  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Genetic Disorders  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Neurological Disorders  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 8. Global Next Generation Cell Therapy Market, By End User, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Hospitals and Cancer Centers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Pharmaceutical and Biotechnology Companies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Contract Development and Manufacturing Organizations (CDMOs)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Academic and Research Institutes  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Specialized Cell Therapy Centers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 9. Global Next Generation Cell Therapy Market, By Region, 2021 - 2033, Value (USD Bn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn) o South Africa o North Africa o Central Africa 10. Competitive Landscape o Novartis AG  Company Highlights  Cell Type Portfolio  Key Developments  Financial Performance  Strategies o Bristol-Myers Squibb Company  Company Highlights  Cell Type Portfolio  Key Developments  Financial Performance  Strategies o Gilead Sciences, Inc.  Company Highlights  Cell Type Portfolio  Key Developments  Financial Performance  Strategies o Johnson & Johnson  Company Highlights  Cell Type Portfolio  Key Developments  Financial Performance  Strategies o Legend Biotech Corporation  Company Highlights  Cell Type Portfolio  Key Developments  Financial Performance  Strategies o Autolus Therapeutics plc  Company Highlights  Cell Type Portfolio  Key Developments  Financial Performance  Strategies o Iovance Biotherapeutics, Inc.  Company Highlights  Cell Type Portfolio  Key Developments  Financial Performance  Strategies o Adaptimmune Therapeutics plc  Company Highlights  Cell Type Portfolio  Key Developments  Financial Performance  Strategies o Allogene Therapeutics, Inc.  Company Highlights  Cell Type Portfolio  Key Developments  Financial Performance  Strategies o CRISPR Therapeutics AG  Company Highlights  Cell Type Portfolio  Key Developments  Financial Performance  Strategies 11. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 12. References and Research Methodology o References o Research Methodology o About us Browse 32 market data tables and 28 figures on ‘Next Generation Cell Therapy Market' - Global forecast to 2033

提及公司

Novartis AGBristol-Myers Squibb CompanyGilead Sciences, Inc.Johnson & JohnsonLegend Biotech CorporationAutolus Therapeutics plcIovance Biotherapeutics, Inc.Adaptimmune Therapeutics plcAllogene Therapeutics, Inc.CRISPR Therapeutics AG

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們